Helix-helix interactions in membrane domains of bitopic proteins: Specificity and role of lipid environment

Biochimica et Biophysica Acta - Biomembranes

Volumn 1859, Issue 4, 2017, Pages 561-576

  Bocharov, Eduard V ^a,c   Mineev, Konstantin S ^a   Pavlov, Konstantin V ^b   Akimov, Sergey A ^b,d   Kuznetsov, Andrey S ^a   Efremov, Roman G ^a,e   Arseniev, Alexander S ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b FRUMKIN INSTITUTE OF PHYSICAL CHEMISTRY AND ELECTROCHEMISTRY   (Russian Federation)

^c KURCHATOV INSTITUTE   (Russian Federation)

^d NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY MISIS   (Russian Federation)

^e NATIONAL RESEARCH UNIVERSITY HIGHER SCHOOL OF ECONOMICS   (Russian Federation)

Author keywords

bitopic membrane protein; lipid density fluctuations; protein lipid and protein protein interactions; receptor tyrosine kinase; signal transduction; transmembrane domain

Indexed keywords

BITOPIC PROTEIN; CELL RECEPTOR; LIPID; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; LIPID BILAYER; MEMBRANE LIPID;

AMINO ACID SEQUENCE; CELL MEMBRANE; DIMERIZATION; HUMAN; LIPID BILAYER; PHYSICS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ALLOSTERISM; ALPHA HELIX; CHEMICAL PHENOMENA; CHEMISTRY; METABOLISM; MOLECULAR MODEL; PROTEIN MULTIMERIZATION; STATIC ELECTRICITY; THERMODYNAMICS;

ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPID BILAYERS; MEMBRANE LIPIDS; MEMBRANE PROTEINS; MODELS, MOLECULAR; PROTEIN CONFORMATION, ALPHA-HELICAL; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; STATIC ELECTRICITY; THERMODYNAMICS;

EID: 85007369942     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2016.10.024     Document Type: Review

References (187)

1. [1] Singer, S.J., Nicolson, G.L., The fluid mosaic model of the structure of cell membranes. Science 175 (1972), 720–731.
2. [2] Nicolson, G.L., The Fluid-Mosaic Model of Membrane Structure: still relevant to understanding the structure, function and dynamics of biological membranes after >�40 years. Biochim. Biophys. Acta 1838 (2014), 1451–1466, 10.1016/j.bbamem.2013.10.019.
3. [3] Simons, K., Ikonen, E., Functional rafts in cell membranes. Nature 387 (1997), 569–572, 10.1038/42408.
4. [4] Samsonov, A.V., Mihalyov, I., Cohen, F.S., Characterization of cholesterol-sphingomyelin domains and their dynamics in bilayer membranes. Biophys. J. 81 (2001), 1486–1500, 10.1016/S0006-3495(01)75803-1.
5. [5] Baumgart, T., Hess, S.T., Webb, W.W., Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension. Nature 425 (2003), 821–824, 10.1038/nature02013.
6. [6] Veatch, S.L., Keller, S.L., Seeing spots: complex phase behavior in simple membranes. Biochim. Biophys. Acta 1746 (2005), 172–185, 10.1016/j.bbamcr.2005.06.010.
7. [7] Ayuyan, A.G., Cohen, F.S., Lipid peroxides promote large rafts: effects of excitation of probes in fluorescence microscopy and electrochemical reactions during vesicle formation. Biophys. J. 91 (2006), 2172–2183, 10.1529/biophysj.106.087387.
8. [8] Veatch, S.L., Cicuta, P., Sengupta, P., Honerkamp-Smith, A., Holowka, D., Baird, B., Critical fluctuations in plasma membrane vesicles. ACS Chem. Biol. 3 (2008), 287–293, 10.1021/cb800012x.
9. [9] Gil, T., Sabra, M.C., Ipsen, J.H., Mouritsen, O.G., Wetting and capillary condensation as means of protein organization in membranes. Biophys. J. 73 (1997), 1728–1741, 10.1016/S0006-3495(97)78204-3.
10. [10] Akimov, S.A., Frolov, V.A.J., Kuzmin, P.I., Zimmerberg, J., Chizmadzhev, Y.A., Cohen, F.S., Domain formation in membranes caused by lipid wetting of protein. Phys. Rev. E Stat. Nonlinear Soft Matter Phys., 77, 2008, 51901, 10.1103/PhysRevE.77.051901.
11. [11] Hedger, G., Sansom, M.S.P., Lipid interaction sites on channels, transporters and receptors: Recent insights from molecular dynamics simulations. Biochim. Biophys. Acta 1858 (2016), 2390–2400.
12. [12] Hulce, J.J., Cognetta, A.B., Niphakis, M.J., Tully, S.E., Cravatt, B.F., Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells. Nat. Methods 10 (2013), 259–264, 10.1038/nmeth.2368.
13. [13] Barrett, P.J., Song, Y., Van Horn, W.D., Hustedt, E.J., Schafer, J.M., Hadziselimovic, A., Beel, A.J., Sanders, C.R., The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336 (2012), 1168–1171, 10.1126/science.1219988.
14. [14] Grouleff, J., Irudayam, S.J., Skeby, K.K., Schi�tt, B., The influence of cholesterol on membrane protein structure, function, and dynamics studied by molecular dynamics simulations. Biochim. Biophys. Acta 1848 (2015), 1783–1795, 10.1016/j.bbamem.2015.03.029.
15. [15] Stangl, M., Schneider, D., Functional competition within a membrane: Lipid recognition vs. transmembrane helix oligomerization. Biochim. Biophys. Acta 1848 (2015), 1886–1896, 10.1016/j.bbamem.2015.03.011.
16. [16] Takamori, S., Holt, M., Stenius, K., Lemke, E.A., Gr�nborg, M., Riedel, D., Urlaub, H., Schenck, S., Br�gger, B., Ringler, P., M�ller, S.A., Rammner, B., Gr�ter, F., Hub, J.S., De Groot, B.L., Mieskes, G., Moriyama, Y., Klingauf, J., Grubm�ller, H., Heuser, J., Wieland, F., Jahn, R., Molecular anatomy of a trafficking organelle. Cell 127 (2006), 831–846, 10.1016/j.cell.2006.10.030.
17. [17] Khuong, T.M., Habets, R.L.P., Kuenen, S., Witkowska, A., Kasprowicz, J., Swerts, J., Jahn, R., van den Bogaart, G., Verstreken, P., Synaptic PI(3,4,5)P3 is required for Syntaxin1A clustering and neurotransmitter release. Neuron 77 (2013), 1097–1108, 10.1016/j.neuron.2013.01.025.
18. [18] Aman, M.J., Ravichandran, K.S., A requirement for lipid rafts in B cell receptor induced Ca(2�+) flux. Curr. Biol. 10 (2000), 393–396, 10.1016/S0960-9822(00)00415-2.
19. [19] Molotkovskaya, I.M., Kholodenko, R.V., Molotkovsky, J.G., Influence of gangliosides on the IL-2- and IL-4-dependent cell proliferation. Neurochem. Res. 27 (2002), 761–770, 10.1023/A:1020248722282.
20. [20] Chen, P.-H., Unger, V., He, X., Structure of Full-Length Human PDGFRβ Bound to Its Activating Ligand PDGF-B as Determined by Negative-Stain Electron Microscopy. J. Mol. Biol. 427 (2015), 3921–3934, 10.1016/j.jmb.2015.10.003.
21. [21] Trenker, R., Call, M.E., Call, M.J., Crystal Structure of the Glycophorin A Transmembrane Dimer in Lipidic Cubic Phase. J. Am. Chem. Soc. 137 (2015), 15676–15679, 10.1021/jacs.5b11354.
22. [22] Ullrich, A., Schlessinger, J., Signal transduction by receptors with tyrosine kinase activity. Cell 61 (1990), 203–212, 10.1016/0092-8674(90)90801-K.
23. [23] Heldin, C.H., Dimerization of cell surface receptors in signal transduction. Cell 80 (1995), 213–223, 10.1016/0092-8674(95)90404-2.
24. [24] Vilar, M., Charalampopoulos, I., Kenchappa, R.S., Simi, A., Karaca, E., Reversi, A., Choi, S., Bothwell, M., Mingarro, I., Friedman, W.J., Schiavo, G., Bastiaens, P.I.H., Verveer, P.J., Carter, B.D., Ib��ez, C.F., Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron 62 (2009), 72–83, 10.1016/j.neuron.2009.02.020.
25. [25] Lemmon, M.A., Schlessinger, J., Cell signaling by receptor tyrosine kinases. Cell 141 (2010), 1117–1134, 10.1016/j.cell.2010.06.011.
26. [26] Shi, Y., Massagu�, J., Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003), 685–700, 10.1016/S0092-8674(03)00432-X.
27. [27] Bocharov, E.V., Pavlov, K.V., Blommers, M.J.J., Arvinte, T., Arseniev, A.S., Modulation of the Bioactive Conformation of Transforming Growth Factor β: Possible Implications of Cation Binding for Biological Function. Top. Curr. Chem. 273 (2008), 155–181, 10.1007/128_2007_17.
28. [28] Landau, M., Fleishman, S.J., Ben-Tal, N., A Putative Mechanism for Downregulation of the Catalytic Activity of the EGF Receptor via Direct Contact between Its Kinase and C-Terminal Domains. Structure 12 (2004), 2265–2275, 10.1016/j.str.2004.10.006.
29. [29] Arkhipov, A., Shan, Y., Das, R., Endres, N.F., Eastwood, M.P., Wemmer, D.E., Kuriyan, J., Shaw, D.E., Architecture and membrane interactions of the EGF receptor. Cell 152 (2013), 557–569, 10.1016/j.cell.2012.12.030.
30. [30] Lemmon, M.A., Ligand-induced ErbB receptor dimerization. Exp. Cell Res. 315 (2009), 638–648, 10.1016/j.yexcr.2008.10.024.
31. [31] Schlessinger, J., Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110 (2002), 669–672, 10.1016/S0092-8674(02)00966-2.
32. [32] Burgess, A.W., Cho, H.-S., Eigenbrot, C., Ferguson, K.M., Garrett, T.P.J., Leahy, D.J., Lemmon, M.A., Sliwkowski, M.X., Ward, C.W., Yokoyama, S., An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol. Cell 12 (2003), 541–552, 10.1016/S1097-2765(03)00350-2.
33. [33] Tao, R.-H., Maruyama, I.N., All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J. Cell Sci. 121 (2008), 3207–3217, 10.1242/jcs.033399.
34. [34] Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C.M., Klein, D.C.G., Monks, B.G., McKnight, C.J., Lamphier, M.S., Duprex, W.P., Espevik, T., Golenbock, D.T., Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat. Immunol. 8 (2007), 772–779, 10.1038/ni1479.
35. [35] Ward, C.W., Lawrence, M.C., Streltsov, V.A., Adams, T.E., McKern, N.M., The insulin and EGF receptor structures: new insights into ligand-induced receptor activation. Trends Biochem. Sci. 32 (2007), 129–137, 10.1016/j.tibs.2007.01.001.
36. [36] Moriki, T., Maruyama, H., Maruyama, I.N., Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 311 (2001), 1011–1026, 10.1006/jmbi.2001.4923.
37. [37] Martin-Fernandez, M., Clarke, D.T., Tobin, M.J., Jones, S.V., Jones, G.R., Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling. Biophys. J. 82 (2002), 2415–2427, 10.1016/S0006-3495(02)75585-9.
38. [38] Clayton, A.H.A., Walker, F., Orchard, S.G., Henderson, C., Fuchs, D., Rothacker, J., Nice, E.C., Burgess, A.W., Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis. J. Biol. Chem. 280 (2005), 30392–30399, 10.1074/jbc.M504770200.
39. [39] Liu, P., Sudhaharan, T., Koh, R.M.L., Hwang, L.C., Ahmed, S., Maruyama, I.N., Wohland, T., Investigation of the dimerization of proteins from the epidermal growth factor receptor family by single wavelength fluorescence cross-correlation spectroscopy. Biophys. J. 93 (2007), 684–698, 10.1529/biophysj.106.102087.
40. [40] Saffarian, S., Li, Y., Elson, E.L., Pike, L.J., Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis. Biophys. J. 93 (2007), 1021–1031, 10.1529/biophysj.107.105494.
41. [41] Ma, X., Ahmed, S., Wohland, T., EGFR activation monitored by SW-FCCS in live cells. Front. Biosci. Elite Ed. 3 (2011), 22–32.
42. [42] Bell, C.A., Tynan, J.A., Hart, K.C., Meyer, A.N., Robertson, S.C., Donoghue, D.J., Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase. Mol. Biol. Cell 11 (2000), 3589–3599, 10.1091/mbc.11.10.3589.
43. [43] Teramura, Y., Ichinose, J., Takagi, H., Nishida, K., Yanagida, T., Sako, Y., Single-molecule analysis of epidermal growth factor binding on the surface of living cells. EMBO J. 25 (2006), 4215–4222, 10.1038/sj.emboj.7601308.
44. [44] Macdonald-Obermann, J.L., Adak, S., Landgraf, R., Piwnica-Worms, D., Pike, L.J., Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging. J. Biol. Chem. 288 (2013), 30773–30784, 10.1074/jbc.M113.489534.
45. [45] Yang, K.S., Ilagan, M.X.G., Piwnica-Worms, D., Pike, L.J., Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor. J. Biol. Chem. 284 (2009), 7474–7482, 10.1074/jbc.M808041200.
46. [46] Yamashita, H., Yano, Y., Kawano, K., Matsuzaki, K., Oligomerization-function relationship of EGFR on living cells detected by the coiled-coil labeling and FRET microscopy. Biochim. Biophys. Acta 1848 (2015), 1359–1366, 10.1016/j.bbamem.2015.03.004.
47. [47] Lin, C.-C., Melo, F.A., Ghosh, R., Suen, K.M., Stagg, L.J., Kirkpatrick, J., Arold, S.T., Ahmed, Z., Ladbury, J.E., Inhibition of basal FGF receptor signaling by dimeric Grb2. Cell 149 (2012), 1514–1524, 10.1016/j.cell.2012.04.033.
48. [48] Shen, J., Maruyama, I.N., Brain-derived neurotrophic factor receptor TrkB exists as a preformed dimer in living cells. J. Mol. Signal., 7, 2012, 2, 10.1186/1750-2187-7-2.
49. [49] Mischel, P.S., Umbach, J.A., Eskandari, S., Smith, S.G., Gundersen, C.B., Zampighi, G.A., Nerve growth factor signals via preexisting TrkA receptor oligomers. Biophys. J. 83 (2002), 968–976, 10.1016/S0006-3495(02)75222-3.
50. [50] Sarabipour, S., Ballmer-Hofer, K., Hristova, K., VEGFR-2 conformational switch in response to ligand binding. eLife, 5, 2016, 10.7554/eLife.13876.
51. [51] Brooks, A.J., Dai, W., O'Mara, M.L., Abankwa, D., Chhabra, Y., Pelekanos, R.A., Gardon, O., Tunny, K.A., Blucher, K.M., Morton, C.J., Parker, M.W., Sierecki, E., Gambin, Y., Gomez, G.A., Alexandrov, K., Wilson, I.A., Doxastakis, M., Mark, A.E., Waters, M.J., Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science, 344, 2014, 1249783, 10.1126/science.1249783.
52. [52] Lu, X., Gross, A.W., Lodish, H.F., Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains. J. Biol. Chem. 281 (2006), 7002–7011, 10.1074/jbc.M512638200.
53. [53] Jiang, G., Hunter, T., Receptor signaling: When dimerization is not enough. Curr. Biol. 9 (1999), R568–R571, 10.1016/S0960-9822(99)80357-1.
54. [54] Fleishman, S.J., Schlessinger, J., Ben-Tal, N., A putative molecular-activation switch in the transmembrane domain of erbB2. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 15937–15940, 10.1073/pnas.252640799.
55. [55] Sharma, N., Longjam, G., Schreiber, G., Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain. J. Biol. Chem. 291 (2016), 3371–3384, 10.1074/jbc.M115.686071.
56. [56] Sorokin, A., Activation of the EGF receptor by insertional mutations in its juxtamembrane regions. Oncogene 11 (1995), 1531–1540.
57. [57] Endres, N.F., Das, R., Smith, A.W., Arkhipov, A., Kovacs, E., Huang, Y., Pelton, J.G., Shan, Y., Shaw, D.E., Wemmer, D.E., Groves, J.T., Kuriyan, J., Conformational Coupling across the Plasma Membrane in Activation of the EGF Receptor. Cell 152 (2013), 543–556, 10.1016/j.cell.2012.12.032.
58. [58] Lu, C., Mi, L.-Z., Grey, M.J., Zhu, J., Graef, E., Yokoyama, S., Springer, T.A., Structural Evidence for Loose Linkage between Ligand Binding and Kinase Activation in the Epidermal Growth Factor Receptor. Mol. Cell. Biol. 30 (2010), 5432–5443, 10.1128/MCB.00742-10.
59. [59] Lu, C., Mi, L.-Z., Sch�rpf, T., Walz, T., Springer, T.A., Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor. J. Biol. Chem. 287 (2012), 38244–38253, 10.1074/jbc.M112.414391.
60. [60] Bessman, N.J., Bagchi, A., Ferguson, K.M., Lemmon, M.A., Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor. Cell Rep. 9 (2014), 1306–1317, 10.1016/j.celrep.2014.10.010.
61. [61] Stanley, A.M., Fleming, K.G., The Transmembrane Domains of ErbB Receptors do not Dimerize Strongly in Micelles. J. Mol. Biol. 347 (2005), 759–772, 10.1016/j.jmb.2005.01.059.
62. [62] Fleming, K.G., Standardizing the Free Energy Change of Transmembrane Helix–Helix Interactions. J. Mol. Biol. 323 (2002), 563–571, 10.1016/S0022-2836(02)00920-8.
63. [63] Mineev, K.S., Lesovoy, D.M., Usmanova, D.R., Goncharuk, S.A., Shulepko, M.A., Lyukmanova, E.N., Kirpichnikov, M.P., Bocharov, E.V., Arseniev, A.S., NMR-based approach to measure the free energy of transmembrane helix–helix interactions. Biochim. Biophys. Acta Biomembr. 1838 (2014), 164–172, 10.1016/j.bbamem.2013.08.021.
64. [64] Duneau, J.-P., Vegh, A.P., Sturgis, J.N., A dimerization hierarchy in the transmembrane domains of the HER receptor family. Biochemistry 46 (2007), 2010–2019, 10.1021/bi061436f.
65. [65] Chen, L., Merzlyakov, M., Cohen, T., Shai, Y., Hristova, K., Energetics of ErbB1 transmembrane domain dimerization in lipid bilayers. Biophys. J. 96 (2009), 4622–4630, 10.1016/j.bpj.2009.03.004.
66. [66] Li, E., You, M., Hristova, K., Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands. Biochemistry 44 (2005), 352–360, 10.1021/bi048480k.
67. [67] Placone, J., Hristova, K., Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET. PLoS One, 7, 2012, e46678, 10.1371/journal.pone.0046678.
68. [68] Merzlyakov, M., You, M., Li, E., Hristova, K., Transmembrane helix heterodimerization in lipid bilayers: probing the energetics behind autosomal dominant growth disorders. J. Mol. Biol. 358 (2006), 1–7, 10.1016/j.jmb.2006.01.086.
69. [69] Merzlyakov, M., Chen, L., Hristova, K., Studies of Receptor Tyrosine Kinase Transmembrane Domain Interactions: The EmEx-FRET Method. J. Membr. Biol. 215 (2007), 93–103, 10.1007/s00232-007-9009-0.
70. [70] Chen, L., Novicky, L., Merzlyakov, M., Hristov, T., Hristova, K., Measuring the energetics of membrane protein dimerization in mammalian membranes. J. Am. Chem. Soc. 132 (2010), 3628–3635, 10.1021/ja910692u.
71. [71] Sarabipour, S., Hristova, K., Glycophorin A transmembrane domain dimerization in plasma membrane vesicles derived from CHO, HEK 293�T, and A431 cells. Biochim. Biophys. Acta 1828 (2013), 1829–1833, 10.1016/j.bbamem.2013.03.022.
72. [72] Sarabipour, S., Hristova, K., Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles. Biochim. Biophys. Acta 1858 (2016), 1436–1442, 10.1016/j.bbamem.2016.03.027.
73. [73] Finger, C., Escher, C., Schneider, D., The Single Transmembrane Domains of Human Receptor Tyrosine Kinases Encode Self-Interactions. Sci. Signal., 2, 2009, 10.1126/scisignal.2000547 (ra56-ra56).
74. [74] Godfroy, J.I., Roostan, M., Moroz, Y.S., Korendovych, I.V., Yin, H., Isolated Toll-like Receptor Transmembrane Domains Are Capable of Oligomerization. PLoS One, 7, 2012, e48875, 10.1371/journal.pone.0048875.
75. [75] Jura, N., Endres, N.F., Engel, K., Deindl, S., Das, R., Lamers, M.H., Wemmer, D.E., Zhang, X., Kuriyan, J., Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment. Cell 137 (2009), 1293–1307, 10.1016/j.cell.2009.04.025.
76. [76] Bennasroune, A., Fickova, M., Gardin, A., Dirrig-Grosch, S., Aunis, D., Cr�mel, G., Hubert, P., Transmembrane peptides as inhibitors of ErbB receptor signaling. Mol. Biol. Cell 15 (2004), 3464–3474, 10.1091/mbc.E03-10-0753.
77. [77] Bargmann, C.I., Hung, M.C., Weinberg, R.A., Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45 (1986), 649–657.
78. [78] Beevers, A.J., Nash, A., Salazar-Cancino, M., Scott, D.J., Notman, R., Dixon, A.M., Effects of the oncogenic V(664)E mutation on membrane insertion, structure, and sequence-dependent interactions of the Neu transmembrane domain in micelles and model membranes: an integrated biophysical and simulation study. Biochemistry 51 (2012), 2558–2568, 10.1021/bi201269w.
79. [79] Sharonov, G.V., Bocharov, E.V., Kolosov, P.M., Astapova, M.V., Arseniev, A.S., Feofanov, A.V., Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase. J. Biol. Chem. 289 (2014), 14955–14964, 10.1074/jbc.M114.558783.
80. [80] Roskoski, R., The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol. Res. 79 (2014), 34–74, 10.1016/j.phrs.2013.11.002.
81. [81] Yamamoto, H., Higasa, K., Sakaguchi, M., Shien, K., Soh, J., Ichimura, K., Furukawa, M., Hashida, S., Tsukuda, K., Takigawa, N., Matsuo, K., Kiura, K., Miyoshi, S., Matsuda, F., Toyooka, S., Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas. J. Natl. Cancer Inst., 106, 2014, 10.1093/jnci/djt338 (djt338).
82. [82] He, L., Hristova, K., Physical-chemical principles underlying RTK activation, and their implications for human disease. Biochim. Biophys. Acta 1818 (2012), 995–1005, 10.1016/j.bbamem.2011.07.044.
83. [83] Manni, S., Mineev, K.S., Usmanova, D., Lyukmanova, E.N., Shulepko, M.A., Kirpichnikov, M.P., Winter, J., Matkovic, M., Deupi, X., Arseniev, A.S., Ballmer-Hofer, K., Structural and functional characterization of alternative transmembrane domain conformations in VEGF receptor 2 activation. Structure 22 (2014), 1077–1089, 10.1016/j.str.2014.05.010.
84. [84] Landau, M., Ben-Tal, N., Dynamic equilibrium between multiple active and inactive conformations explains regulation and oncogenic mutations in ErbB receptors. Biochim. Biophys. Acta 1785 (2008), 12–31, 10.1016/j.bbcan.2007.08.001.
85. [85] Del Piccolo, N., Placone, J., Hristova, K., Effect of thanatophoric dysplasia type I mutations on FGFR3 dimerization. Biophys. J. 108 (2015), 272–278, 10.1016/j.bpj.2014.11.3460.
86. [86] Xie, D., Shu, X.O., Deng, Z., Wen, W.Q., Creek, K.E., Dai, Q., Gao, Y.T., Jin, F., Zheng, W., Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J. Natl. Cancer Inst. 92 (2000), 412–417, 10.1093/jnci/92.5.412.
87. [87] Dosch, D.D., Ballmer-Hofer, K., Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers. FASEB J. 24 (2010), 32–38, 10.1096/fj.09-132670.
88. [88] Nishiya, T., Kajita, E., Miwa, S., Ligand-independent oligomerization of TLR4 regulated by a short hydrophobic region adjacent to the transmembrane domain. Biochem. Biophys. Res. Commun. 341 (2006), 1128–1134, 10.1016/j.bbrc.2006.01.074.
89. [89] Coulson, E.J., Reid, K., Baca, M., Shipham, K.A., Hulett, S.M., Kilpatrick, T.J., Bartlett, P.F., Chopper, a new death domain of the p75 neurotrophin receptor that mediates rapid neuronal cell death. J. Biol. Chem. 275 (2000), 30537–30545, 10.1074/jbc.M005214200.
90. [90] Coulson, E.J., Reid, K., Shipham, K.M., Morley, S., Kilpatrick, T.J., Bartlett, P.F., The role of neurotransmission and the Chopper domain in p75 neurotrophin receptor death signaling. Prog. Brain Res. 146 (2004), 41–62, 10.1016/S0079-6123(03)46003-2.
91. [91] Red Brewer, M., Choi, S.H., Alvarado, D., Moravcevic, K., Pozzi, A., Lemmon, M.A., Carpenter, G., The juxtamembrane region of the EGF receptor functions as an activation domain. Mol. Cell 34 (2009), 641–651, 10.1016/j.molcel.2009.04.034.
92. [92] Choowongkomon, K., Carlin, C.R., S�nnichsen, F.D., A structural model for the membrane-bound form of the juxtamembrane domain of the epidermal growth factor receptor. J. Biol. Chem. 280 (2005), 24043–24052, 10.1074/jbc.M502698200.
93. [93] Bragin, P.E., Mineev, K.S., Bocharova, O.V., Volynsky, P.E., Bocharov, E.V., Arseniev, A.S., HER2 Transmembrane Domain Dimerization Coupled with Self-Association of Membrane-Embedded Cytoplasmic Juxtamembrane Regions. J. Mol. Biol. 428 (2016), 52–61, 10.1016/j.jmb.2015.11.007.
94. [94] Mineev, K.S., Panova, S.V., Bocharova, O.V., Bocharov, E.V., Arseniev, A.S., The Membrane Mimetic Affects the Spatial Structure and Mobility of EGFR Transmembrane and Juxtamembrane Domains. Biochemistry 54 (2015), 6295–6298, 10.1021/acs.biochem.5b00851.
95. [95] Matsushita, C., Tamagaki, H., Miyazawa, Y., Aimoto, S., Smith, S.O., Sato, T., Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides. Proc. Natl. Acad. Sci. 110 (2013), 1646–1651, 10.1073/pnas.1215207110.
96. [96] Tamagaki, H., Furukawa, Y., Yamaguchi, R., Hojo, H., Aimoto, S., Smith, S.O., Sato, T., Coupling of transmembrane helix orientation to membrane release of the juxtamembrane region in FGFR3. Biochemistry 53 (2014), 5000–5007, 10.1021/bi500327q.
97. [97] Deng, W., Li, R., Juxtamembrane contribution to transmembrane signaling. Biopolymers 104 (2015), 317–322, 10.1002/bip.22651.
98. [98] Lemmon, M.A., Flanagan, J.M., Hunt, J.F., Adair, B.D., Bormann, B.J., Dempsey, C.E., Engelman, D.M., Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices. J. Biol. Chem. 267 (1992), 7683–7689.
99. [99] Russ, W.P., Engelman, D.M., The GxxxG motif: a framework for transmembrane helix-helix association. J. Mol. Biol. 296 (2000), 911–919, 10.1006/jmbi.1999.3489.
100. [100] Teese, M.G., Langosch, D., Role of GxxxG Motifs in Transmembrane Domain Interactions. Biochemistry 54 (2015), 5125–5135, 10.1021/acs.biochem.5b00495.
101. [101] Sulistijo, E.S., Jaszewski, T.M., MacKenzie, K.R., Sequence-specific dimerization of the transmembrane domain of the “BH3-only” protein BNIP3 in membranes and detergent. J. Biol. Chem. 278 (2003), 51950–51956, 10.1074/jbc.M308429200.
102. [102] Sulistijo, E.S., MacKenzie, K.R., Sequence dependence of BNIP3 transmembrane domain dimerization implicates side-chain hydrogen bonding and a tandem GxxxG motif in specific helix-helix interactions. J. Mol. Biol. 364 (2006), 974–990, 10.1016/j.jmb.2006.09.065.
103. [103] MacKenzie, K.R., Prestegard, J.H., Engelman, D.M., A transmembrane helix dimer: structure and implications. Science 276 (1997), 131–133, 10.1126/science.276.5309.131.
104. [104] Mineev, K.S., Bocharov, E.V., Volynsky, P.E., Goncharuk, M.V., Tkach, E.N., Ermolyuk, Y.S., Schulga, A.A., Chupin, V.V., Maslennikov, I.V., Efremov, R.G., Arseniev, A.S., Dimeric structure of the transmembrane domain of glycophorin a in lipidic and detergent environments. Acta Nat. 3 (2011), 90–98 ( http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347579).
105. [105] Smith, S.O., Song, D., Shekar, S., Groesbeek, M., Ziliox, M., Aimoto, S., Structure of the transmembrane dimer interface of glycophorin A in membrane bilayers. Biochemistry 40 (2001), 6553–6558, 10.1021/bi010357v.
106. [106] Bocharov, E.V., Pustovalova, Y.E., Pavlov, K.V., Volynsky, P.E., Goncharuk, M.V., Ermolyuk, Y.S., Karpunin, D.V., Schulga, A.A., Kirpichnikov, M.P., Efremov, R.G., Maslennikov, I.V., Arseniev, A.S., Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger. J. Biol. Chem. 282 (2007), 16256–16266, 10.1074/jbc.M701745200.
107. [107] Sulistijo, E.S., Mackenzie, K.R., Structural basis for dimerization of the BNIP3 transmembrane domain. Biochemistry 48 (2009), 5106–5120, 10.1021/bi802245u.
108. [108] Bocharov, E.V., Mineev, K.S., Volynsky, P.E., Ermolyuk, Y.S., Tkach, E.N., Sobol, A.G., Chupin, V.V., Kirpichnikov, M.P., Efremov, R.G., Arseniev, A.S., Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state. J. Biol. Chem. 283 (2008), 6950–6956, 10.1074/jbc.M709202200.
109. [109] Bocharov, E.V., Mineev, K.S., Goncharuk, M.V., Arseniev, A.S., Structural and thermodynamic insight into the process of “weak” dimerization of the ErbB4 transmembrane domain by solution NMR. Biochim. Biophys. Acta 1818 (2012), 2158–2170, 10.1016/j.bbamem.2012.05.001.
110. [110] Mineev, K.S., Bocharov, E.V., Pustovalova, Y.E., Bocharova, O.V., Chupin, V.V., Arseniev, A.S., Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases. J. Mol. Biol. 400 (2010), 231–243, 10.1016/j.jmb.2010.05.016.
111. [111] Bocharov, E.V., Mayzel, M.L., Volynsky, P.E., Goncharuk, M.V., Ermolyuk, Y.S., Schulga, A.A., Artemenko, E.O., Efremov, R.G., Arseniev, A.S., Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1. J. Biol. Chem. 283 (2008), 29385–29395, 10.1074/jbc.M803089200.
112. [112] Lau, T.-L., Kim, C., Ginsberg, M.H., Ulmer, T.S., The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J. 28 (2009), 1351–1361, 10.1038/emboj.2009.63.
113. [113] Yang, J., Ma, Y.-Q., Page, R.C., Misra, S., Plow, E.F., Qin, J., Structure of an integrin alphaIIb beta3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 17729–17734, 10.1073/pnas.0909589106.
114. [114] Mokrab, Y., Stevens, T.J., Mizuguchi, K., Lipophobicity and the residue environments of the transmembrane alpha-helical bundle. Proteins 74 (2009), 32–49, 10.1002/prot.22130.
115. [115] Wimley, W.C., White, S.H., Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3 (1996), 842–848, 10.1038/nsb1096-842.
116. [116] Senes, A., Ubarretxena-Belandia, I., Engelman, D.M., The Calpha –-H…O hydrogen bond: a determinant of stability and specificity in transmembrane helix interactions. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 9056–9061, 10.1073/pnas.161280798.
117. [117] Manikandan, K., Ramakumar, S., The occurrence of C–H…O hydrogen bonds in alpha-helices and helix termini in globular proteins. Proteins 56 (2004), 768–781, 10.1002/prot.20152.
118. [118] Park, H., Yoon, J., Seok, C., Strength of Calpha-H…O�=�C hydrogen bonds in transmembrane proteins. J. Phys. Chem. B 112 (2008), 1041–1048, 10.1021/jp077285n.
119. [119] Mottamal, M., Lazaridis, T., The contribution of C alpha-H…O hydrogen bonds to membrane protein stability depends on the position of the amide. Biochemistry (Mosc) 44 (2005), 1607–1613, 10.1021/bi048065s.
120. [120] Cordier, F., Barfield, M., Grzesiek, S., Direct observation of Calpha-Halpha…O�=�C hydrogen bonds in proteins by interresidue h3JCalphaC’ scalar couplings. J. Am. Chem. Soc. 125 (2003), 15750–15751, 10.1021/ja038616m.
121. [121] Mineev, K.S., Goncharuk, S.A., Arseniev, A.S., Toll-like receptor 3 transmembrane domain is able to perform various homotypic interactions: an NMR structural study. FEBS Lett. 588 (2014), 3802–3807, 10.1016/j.febslet.2014.08.031.
122. [122] Russ, W.P., Engelman, D.M., TOXCAT: a measure of transmembrane helix association in a biological membrane. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 863–868, 10.1073/pnas.96.3.863.
123. [123] Zhou, F.X., Merianos, H.J., Brunger, A.T., Engelman, D.M., Polar residues drive association of polyleucine transmembrane helices. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 2250–2255, 10.1073/pnas.041593698.
124. [124] Walters, R.F.S., DeGrado, W.F., Helix-packing motifs in membrane proteins. Proc. Natl. Acad. Sci. 103 (2006), 13658–13663, 10.1073/pnas.0605878103.
125. [125] Zhang, S.-Q., Kulp, D.W., Schramm, C.A., Mravic, M., Samish, I., DeGrado, W.F., The membrane- and soluble-protein helix-helix interactome: similar geometry via different interactions. Structure 1993:23 (2015), 527–541, 10.1016/j.str.2015.01.009.
126. [126] Bocharov, E., Mayzel, M., Volynsky, P., Mineev, K., Tkach, E., Ermolyuk, Y., Schulga, A., Efremov, R., Arseniev, A., Left-Handed Dimer of EphA2 Transmembrane Domain: Helix Packing Diversity among Receptor Tyrosine Kinases. Biophys. J. 98 (2010), 881–889, 10.1016/j.bpj.2009.11.008.
127. [127] Muhle-Goll, C., Hoffmann, S., Afonin, S., Grage, S.L., Polyansky, A.A., Windisch, D., Zeitler, M., Burck, J., Ulrich, A.S., Hydrophobic Matching Controls the Tilt and Stability of the Dimeric Platelet-derived Growth Factor Receptor (PDGFR) Transmembrane Segment. J. Biol. Chem. 287 (2012), 26178–26186, 10.1074/jbc.M111.325555.
128. [128] Bocharov, E.V., Lesovoy, D.M., Goncharuk, S.A., Goncharuk, M.V., Hristova, K., Arseniev, A.S., Structure of FGFR3 transmembrane domain dimer: implications for signaling and human pathologies. Structure 1993:21 (2013), 2087–2093, 10.1016/j.str.2013.08.026.
129. [129] Call, M.E., Schnell, J.R., Xu, C., Lutz, R.A., Chou, J.J., Wucherpfennig, K.W., The Structure of the ζζ Transmembrane Dimer Reveals Features Essential for Its Assembly with the T Cell Receptor. Cell 127 (2006), 355–368, 10.1016/j.cell.2006.08.044.
130. [130] Call, M.E., Wucherpfennig, K.W., Chou, J.J., The structural basis for intramembrane assembly of an activating immunoreceptor complex. Nat. Immunol. 11 (2010), 1023–1029, 10.1038/ni.1943.
131. [131] Stein, A., Weber, G., Wahl, M.C., Jahn, R., Helical extension of the neuronal SNARE complex into the membrane. Nature 460 (2009), 525–528, 10.1038/nature08156.
132. [132] Sarabipour, S., Hristova, K., Mechanism of FGF receptor dimerization and activation. Nat. Commun., 7, 2016, 10262, 10.1038/ncomms10262.
133. [133] Dominguez, L., Foster, L., Straub, J.E., Thirumalai, D., Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein. Proc. Natl. Acad. Sci. 113 (2016), E5281–E5287, 10.1073/pnas.1606482113.
134. [134] Bocharov, E.V., Lesovoy, D.M., Pavlov, K.V., Pustovalova, Y.E., Bocharova, O.V., Arseniev, A.S., Alternative packing of EGFR transmembrane domain suggests that protein-lipid interactions underlie signal conduction across membrane. Biochim. Biophys. Acta 1858 (2016), 1254–1261, 10.1016/j.bbamem.2016.02.023.
135. [135] Mineev, K.S., Khabibullina, N.F., Lyukmanova, E.N., Dolgikh, D.A., Kirpichnikov, M.P., Arseniev, A.S., Spatial structure and dimer–monomer equilibrium of the ErbB3 transmembrane domain in DPC micelles. Biochim. Biophys. Acta 1808 (2011), 2081–2088, 10.1016/j.bbamem.2011.04.017.
136. [136] Nadezhdin, K.D., Garc�a-Carpio, I., Goncharuk, S.A., Mineev, K.S., Arseniev, A.S., Vilar, M., Structural Basis of p75 Transmembrane Domain Dimerization. J. Biol. Chem. 291 (2016), 12346–12357, 10.1074/jbc.M116.723585.
137. [137] Nadezhdin, K.D., Bocharova, O.V., Bocharov, E.V., Arseniev, A.S., Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environment. FEBS Lett. 586 (2012), 1687–1692, 10.1016/j.febslet.2012.04.062.
138. [138] Volynsky, P.E., Polyansky, A.A., Fakhrutdinova, G.N., Bocharov, E.V., Efremov, R.G., Role of dimerization efficiency of transmembrane domains in activation of fibroblast growth factor receptor 3. J. Am. Chem. Soc. 135 (2013), 8105–8108, 10.1021/ja4011942.
139. [139] Escher, C., Cymer, F., Schneider, D., Two GxxxG-like motifs facilitate promiscuous interactions of the human ErbB transmembrane domains. J. Mol. Biol. 389 (2009), 10–16, 10.1016/j.jmb.2009.04.002.
140. [140] Mineev, K.S., Goncharuk, S.A., Kuzmichev, P.K., Vilar, M., Arseniev, A.S., NMR Dynamics of Transmembrane and Intracellular Domains of p75NTR in Lipid-Protein Nanodiscs. Biophys. J. 109 (2015), 772–782, 10.1016/j.bpj.2015.07.009.
141. [141] Anbazhagan, V., Schneider, D., The membrane environment modulates self-association of the human GpA TM domain—Implications for membrane protein folding and transmembrane signaling. Biochim. Biophys. Acta Biomembr. 1798 (2010), 1899–1907, 10.1016/j.bbamem.2010.06.027.
142. [142] Mall, S., Broadbridge, R., Sharma, R.P., East, J.M., Lee, A.G., Self-association of model transmembrane alpha-helices is modulated by lipid structure. Biochemistry 40 (2001), 12379–12386, 10.1021/bi011075y.
143. [143] Cristian, L., Lear, J.D., DeGrado, W.F., Use of thiol-disulfide equilibria to measure the energetics of assembly of transmembrane helices in phospholipid bilayers. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 14772–14777, 10.1073/pnas.2536751100.
144. [144] Kuznetsov, A.S., Polyansky, A.A., Fleck, M., Volynsky, P.E., Efremov, R.G., Adaptable Lipid Matrix Promotes Protein-Protein Association in Membranes. J. Chem. Theory Comput. 11 (2015), 4415–4426, 10.1021/acs.jctc.5b00206.
145. [145] Yoo, W.-J., Capdevila, M.G., Du, X., Kobayashi, S., Base-Mediated Carboxylation of Unprotected Indole Derivatives with Carbon Dioxide. Org. Lett. 14 (2012), 5326–5329, 10.1021/ol3025082.
146. [146] Parton, D.L., Tek, A., Baaden, M., Sansom, M.S.P., Formation of raft-like assemblies within clusters of influenza hemagglutinin observed by MD simulations. PLoS Comput. Biol., 9, 2013, e1003034, 10.1371/journal.pcbi.1003034.
147. [147] Sengupta, D., Marrink, S.J., Lipid-mediated interactions tune the association of glycophorin A helix and its disruptive mutants in membranes. Phys. Chem. Chem. Phys. 12 (2010), 12987–12996, 10.1039/c0cp00101e.
148. [148] Kuznetsov, A.S., Volynsky, P.E., Efremov, R.G., Role of the Lipid Environment in the Dimerization of Transmembrane Domains of Glycophorin A. Acta Nat. 7 (2015), 122–127 ( https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717257).
149. [149] Pyrkova, D.V., Tarasova, N.K., Krylov, N.A., Nolde, D.E., Pentkovsky, V.M., Efremov, R.G., Dynamic clustering of lipids in hydrated two-component membranes: results of computer modeling and putative biological impact. J. Biomol. Struct. Dyn. 31 (2013), 87–95, 10.1080/07391102.2012.691365.
150. [150] Hong, H., Toward understanding driving forces in membrane protein folding. Arch. Biochem. Biophys. 564 (2014), 297–313, 10.1016/j.abb.2014.07.031.
151. [151] Efremov, R.G., Vergoten, G., Hydrophobic Nature of Membrane-Spanning.alpha.-Helical Peptides as Revealed by Monte Carlo Simulations and Molecular Hydrophobicity Potential Analysis. J. Phys. Chem. 99 (1995), 10658–10666, 10.1021/j100026a033.
152. [152] Polyansky, A.A., Volynsky, P.E., Efremov, R.G., Multistate organization of transmembrane helical protein dimers governed by the host membrane. J. Am. Chem. Soc. 134 (2012), 14390–14400, 10.1021/ja303483k.
153. [153] Domański, J., Marrink, S.J., Sch�fer, L.V., Transmembrane helices can induce domain formation in crowded model membranes. Biochim. Biophys. Acta 1818 (2012), 984–994, 10.1016/j.bbamem.2011.08.021.
154. [154] de Meyer, F.J.-M., Rodgers, J.M., Willems, T.F., Smit, B., Molecular simulation of the effect of cholesterol on lipid-mediated protein-protein interactions. Biophys. J. 99 (2010), 3629–3638, 10.1016/j.bpj.2010.09.030.
155. [155] Hedger, G., Sansom, M.S.P., Kolds�, H., The juxtamembrane regions of human receptor tyrosine kinases exhibit conserved interaction sites with anionic lipids. Sci. Rep., 5, 2015, 9198, 10.1038/srep09198.
156. [156] Chakraborty, S., Veettil, M.V., Bottero, V., Chandran, B., Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E1163–E1172, 10.1073/pnas.1119592109.
157. [157] Tawadros, T., Brown, M.D., Hart, C.A., Clarke, N.W., Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells. Br. J. Cancer 107 (2012), 1737–1744, 10.1038/bjc.2012.457.
158. [158] Chavent, M., Seiradake, E., Jones, E.Y., Sansom, M.S.P., Structures of the EphA2 Receptor at the Membrane: Role of Lipid Interactions. Structure 24 (2016), 337–347, 10.1016/j.str.2015.11.008.
159. [159] Hofman, E.G., Ruonala, M.O., Bader, A.N., van den Heuvel, D., Voortman, J., Roovers, R.C., Verkleij, A.J., Gerritsen, H.C., P.M.P. van Bergen En Henegouwen, EGF induces coalescence of different lipid rafts. J. Cell Sci. 121 (2008), 2519–2528, 10.1242/jcs.028753.
160. [160] Petrache, H.I., Grossfield, A., MacKenzie, K.R., Engelman, D.M., Woolf, T.B., Modulation of glycophorin A transmembrane helix interactions by lipid bilayers: molecular dynamics calculations. J. Mol. Biol. 302 (2000), 727–746, 10.1006/jmbi.2000.4072.
161. [161] Flinner, N., Schleiff, E., Dynamics of the Glycophorin A Dimer in Membranes of Native-Like Composition Uncovered by Coarse-Grained Molecular Dynamics Simulations. PLoS One, 10, 2015, e0133999, 10.1371/journal.pone.0133999.
162. [162] Hong, H., Bowie, J.U., Dramatic destabilization of transmembrane helix interactions by features of natural membrane environments. J. Am. Chem. Soc. 133 (2011), 11389–11398, 10.1021/ja204524c.
163. [163] Zhernenkov, M., Bolmatov, D., Soloviov, D., Zhernenkov, K., Toperverg, B.P., Cunsolo, A., Bosak, A., Cai, Y.Q., Revealing the mechanism of passive transport in lipid bilayers via phonon-mediated nanometre-scale density fluctuations. Nat. Commun., 7, 2016, 11575, 10.1038/ncomms11575.
164. [164] Collins, M.D., Keller, S.L., Tuning lipid mixtures to induce or suppress domain formation across leaflets of unsupported asymmetric bilayers. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 124–128, 10.1073/pnas.0702970105.
165. [165] Blosser, M.C., Honerkamp-Smith, A.R., Han, T., Haataja, M., Keller, S.L., Transbilayer Colocalization of Lipid Domains Explained via Measurement of Strong Coupling Parameters. Biophys. J. 109 (2015), 2317–2327, 10.1016/j.bpj.2015.10.031.
166. [166] Horner, A., Akimov, S.A., Pohl, P., Long and short lipid molecules experience the same interleaflet drag in lipid bilayers. Phys. Rev. Lett., 110, 2013, 268101, 10.1103/PhysRevLett.110.268101.
167. [167] Horner, A., Antonenko, Y.N., Pohl, P., Coupled diffusion of peripherally bound peptides along the outer and inner membrane leaflets. Biophys. J. 96 (2009), 2689–2695, 10.1016/j.bpj.2008.12.3931.
168. [168] Rukmini, R., Rawat, S.S., Biswas, S.C., Chattopadhyay, A., Cholesterol organization in membranes at low concentrations: effects of curvature stress and membrane thickness. Biophys. J. 81 (2001), 2122–2134, 10.1016/S0006-3495(01)75860-2.
169. [169] Pantano, D.A., Moore, P.B., Klein, M.L., Discher, D.E., Raft registration across bilayers in a molecularly detailed model. Soft Matter, 7, 2011, 8182, 10.1039/c1sm05490b.
170. [170] Galimzyanov, T.R., Molotkovsky, R.J., Bozdaganyan, M.E., Cohen, F.S., Pohl, P., Akimov, S.A., Elastic Membrane Deformations Govern Interleaflet Coupling of Lipid-Ordered Domains. Phys. Rev. Lett., 115, 2015, 88101, 10.1103/PhysRevLett.115.088101.
171. [171] Risselada, H.J., Marrink, S.J., The molecular face of lipid rafts in model membranes. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 17367–17372, 10.1073/pnas.0807527105.
172. [172] Perlmutter, J.D., Sachs, J.N., Interleaflet interaction and asymmetry in phase separated lipid bilayers: molecular dynamics simulations. J. Am. Chem. Soc. 133 (2011), 6563–6577, 10.1021/ja106626r.
173. [173] Galimzyanov, T.R., Kuzmin, P.I., Pohl, P., Akimov, S.A., Elastic deformations of bolalipid membranes. Soft Matter 12 (2016), 2357–2364, 10.1039/c5sm02635k.
174. [174] Galimzyanov, T.R., Molotkovsky, R.J., Cohen, F.S., Pohl, P., Akimov, S.A., Reply. Phys. Rev. Lett., 116, 2016, 79802, 10.1103/PhysRevLett.116.079802.
175. [175] Baumgart, T., Das, S., Webb, W.W., Jenkins, J.T., Membrane elasticity in giant vesicles with fluid phase coexistence. Biophys. J. 89 (2005), 1067–1080, 10.1529/biophysj.104.049692.
176. [176] Pan, J., Tieleman, D.P., Nagle, J.F., Kucerka, N., Tristram-Nagle, S., Alamethicin in lipid bilayers: combined use of X-ray scattering and MD simulations. Biochim. Biophys. Acta 1788 (2009), 1387–1397, 10.1016/j.bbamem.2009.02.013.
177. [177] Pan, J., Tristram-Nagle, S., Nagle, J.F., Effect of cholesterol on structural and mechanical properties of membranes depends on lipid chain saturation. Phys. Rev. E Stat. Nonlinear Soft Matter Phys., 80, 2009, 21931, 10.1103/PhysRevE.80.021931.
178. [178] Volynsky, P.E., Polyansky, A.A., Simakov, N.A., Arseniev, A.S., Efremov, R.G., Effect of lipid composition on the “membrane response” induced by a fusion peptide. Biochemistry 44 (2005), 14626–14637, 10.1021/bi0514562.
179. [179] Sengupta, D., Leontiadou, H., Mark, A.E., Marrink, S.-J., Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim. Biophys. Acta 1778 (2008), 2308–2317, 10.1016/j.bbamem.2008.06.007.
180. [180] Polyansky, A.A., Volynsky, P.E., Arseniev, A.S., Efremov, R.G., Adaptation of a membrane-active peptide to heterogeneous environment. II. The role of mosaic nature of the membrane surface. J. Phys. Chem. B 113 (2009), 1120–1126, 10.1021/jp803641x.
181. [181] Nguyen, L.T., Haney, E.F., Vogel, H.J., The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 29 (2011), 464–472, 10.1016/j.tibtech.2011.05.001.
182. [182] Simons, K., Toomre, D., Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1 (2000), 31–39, 10.1038/35036052.
183. [183] McLaughlin, S., Smith, S.O., Hayman, M.J., Murray, D., An Electrostatic Engine Model for Autoinhibition and Activation of the Epidermal Growth Factor Receptor (EGFR/ErbB) Family. J. Gen. Physiol. 126 (2005), 41–53, 10.1085/jgp.200509274.
184. [184] Lemmon, M.A., Schlessinger, J., Ferguson, K.M., The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol., 6, 2014, a020768, 10.1101/cshperspect.a020768.
185. [185] Kovacs, E., Zorn, J.A., Huang, Y., Barros, T., Kuriyan, J., A structural perspective on the regulation of the epidermal growth factor receptor. Annu. Rev. Biochem. 84 (2015), 739–764, 10.1146/annurev-biochem-060614-034402.
186. [186] Nadezhdin, K.D., Bocharova, O.V., Bocharov, E.V., Arseniev, A.S., Structural and dynamic study of the transmembrane domain of the amyloid precursor protein. Acta Nat. 3 (2011), 69–76 ( http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347594).
187. [187] Coskun, U., Grzybek, M., Drechsel, D., Simons, K., Regulation of human EGF receptor by lipids. Proc. Natl. Acad. Sci. 108 (2011), 9044–9048, 10.1073/pnas.1105666108.